BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 15096088)

  • 1. Endogenic and iatrogenic diabetes mellitus in drug-naïve schizophrenia: the role of olanzapine and its place in the psychopharmacological treatment algorithm.
    Cohen D; De Hert M
    Neuropsychopharmacology; 2011 Oct; 36(11):2368-9. PubMed ID: 21918520
    [No Abstract]   [Full Text] [Related]  

  • 2. Olanzapine-induced diabetic ketoacidosis and neuroleptic malignant syndrome with rhabdomyolysis: a case report.
    Sa YK; Yang H; Jung HK; Son JW; Lee SS; Kim SR; Cha BY; Son HY; Pae CU; Yoo SJ
    Endocrinol Metab (Seoul); 2013 Mar; 28(1):70-5. PubMed ID: 24396655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus during olanzapine and quetiapine treatment in Japan.
    Cohen D
    J Clin Psychiatry; 2005 Feb; 66(2):265-6; author reply 266-7. PubMed ID: 15705015
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperglycemia in patients with schizophrenia who are treated with olanzapine.
    Lindenmayer JP; Smith RC; Singh A; Parker B; Chou E; Kotsaftis A
    J Clin Psychopharmacol; 2001 Jun; 21(3):351-3. PubMed ID: 11386505
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine in schizophrenia and affective disorders.
    Undurraga J; Vieta E; Tohen M; Colom F
    Drug Saf; 2012 Dec; 35(12):1185-6; author reply 1186. PubMed ID: 23137154
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic parameters and long-term antipsychotic treatment: a comparison between patients treated with clozapine or olanzapine.
    Feng S; Melkersson K
    Neuro Endocrinol Lett; 2012; 33(5):493-8. PubMed ID: 23090266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy with antipsychotic drugs as a risk factor for diabetes in schizophrenia: a case-control study].
    Rubio G; Gómez-de-la-Cámara A; Ledesma F; Burón JA; Rodríguez-Morales A; Martínez-Junquera G;
    Med Clin (Barc); 2006 Apr; 126(12):441-4. PubMed ID: 16620729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of hyperglycemia in patients treated with olanzapine.
    Misawa F; Miyaji S; Fuji Y; Miyata R; Obi K; Koshiishi F; Shimada H; Fukuda M; Koizumi T
    J Clin Psychiatry; 2004 Mar; 65(3):443-4. PubMed ID: 15096088
    [No Abstract]   [Full Text] [Related]  

  • 9. Life-threatening hyperglycemia and acidosis related to olanzapine: a case report and review of the literature.
    Varma MK; Connolly K; Fulton B
    J Intensive Care Med; 2007; 22(1):52-5. PubMed ID: 17259569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemia associated with the use of atypical antipsychotics.
    Lindenmayer JP; Nathan AM; Smith RC
    J Clin Psychiatry; 2001; 62 Suppl 23():30-8. PubMed ID: 11603883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of olanzapine use in adolescents.
    Schulz C; Haight RJ
    Expert Opin Drug Saf; 2013 Sep; 12(5):777-82. PubMed ID: 23876012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Olanzapine].
    Nagai N; Watanabe K
    Nihon Rinsho; 2013 Apr; 71(4):666-72. PubMed ID: 23678597
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.